Ulrik Carling

  • Interventional radiologist; MD, PhD
 

Publications 2024

Carling U (2024)
Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization: A Comment
Cardiovasc Intervent Radiol, 47 (5), 650-651
DOI 10.1007/s00270-024-03715-y, PubMed 38600331

Carling U, Berger S, Gjønnæss E, Røsok B, Yaqub S, Lassen K, Fretland ÅA, Dorenberg E (2024)
Transfemoral hepatic vein access in double vein embolization - initial experience and feasibility
CVIR Endovasc, 7 (1), 64
DOI 10.1186/s42155-024-00478-y, PubMed 39225967

Publications 2023

Carling U (2023)
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach: A Comment
Cardiovasc Intervent Radiol, 46 (12), 1713-1714
DOI 10.1007/s00270-023-03595-8, PubMed 37940738

Schrøder-Aasen AM, Carling U, Aaløkken TM, Rasmussen MK, Dorenberg E (2023)
Intraoperative computed tomography during fenestrated and branched endovascular aortic repair: a feasibility study
Acta Radiol, 64 (6), 2205-2210
DOI 10.1177/02841851231165673, PubMed 37116869

Publications 2022

Carling U, Røsok B, Berger S, Fretland ÅA, Dorenberg E (2022)
Reply to Letter to the Editor: Portal Vein Embolization with Vascular Plug and n-Butyl Cyanoacrylate: Are We There Yet?
Cardiovasc Intervent Radiol, 45 (10), 1549-1550
DOI 10.1007/s00270-022-03239-3, PubMed 36008573

Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, van Baardewijk LJ, Baclija I, Bent C, Bertrand CL, Björnsson B, de Boer MT, de Boer SW, Bokkers RPH, Rinkes IHMB, Breitenstein S, Bruijnen RCG, Bruners P, Büchler MW, Camacho JC, Cappelli A, Carling U, Chan BKY, Chang DH, Choi J et al. (2022)
Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy
Cardiovasc Intervent Radiol, 45 (9), 1391-1398
DOI 10.1007/s00270-022-03176-1, PubMed 35790566

Publications 2021

Carling U, Røsok B, Berger S, Fretland ÅA, Dorenberg E (2021)
Portal Vein Embolization Using N-Butyl Cyanoacrylate-Glue: What Impact Does a Central Vascular Plug Have?
Cardiovasc Intervent Radiol, 45 (4), 450-458
DOI 10.1007/s00270-021-03014-w, PubMed 34907454

Dueland S, Yaqub S, Syversveen T, Carling U, Hagness M, Brudvik KW, Line PD (2021)
Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases
JAMA Surg, 156 (6), 550-557
DOI 10.1001/jamasurg.2021.0267, PubMed 33787838

Heil J, Heid F, Bechstein WO, Björnsson B, Brismar TB, Carling U, Erdmann J, Fretland ÅA, Grunhagen D, Hana RA, Hohmann J, Linke R, Meyer Y, Nawawi A, Olthof PB, Sandström P, Schnitzbauer AA, Sparrelid E, Verhoef C, Metrakos P, Schadde E (2021)
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients
HPB (Oxford), 24 (3), 413-421
DOI 10.1016/j.hpb.2021.08.818, PubMed 34526229

Sparrelid E, Hasselgren K, Røsok BI, Larsen PN, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Björnsson B (2021)
How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility
Hepatobiliary Surg Nutr, 10 (1), 1-8
DOI 10.21037/hbsn.2019.10.36, PubMed 33575285

Publications 2020

Björnsson B, Hasselgren K, Røsok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Sparrelid E (2020)
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study
Int J Surg, 75, 60-65
DOI 10.1016/j.ijsu.2020.01.129, PubMed 32001330

Publications 2019

Carling U, Barkhatov L, Reims HM, Storås T, Courivaud F, Kazaryan AM, Halvorsen PS, Dorenberg E, Edwin B, Hol PK (2019)
Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model
Eur Radiol, 29 (9), 5013-5021
DOI 10.1007/s00330-018-5996-8, PubMed 30737565

Røsok BI, Høst-Brunsell T, Brudvik KW, Carling U, Dorenberg E, Björnsson B, Lothe RA, Bjørnbeth BA, Sandström P (2019)
Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT
HPB (Oxford), 21 (8), 1017-1023
DOI 10.1016/j.hpb.2018.12.003, PubMed 30765198

Publications 2018

Carling U, Røsok B, Line PD, Dorenberg EJ (2018)
ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma
Acta Radiol, 60 (6), 702-709
DOI 10.1177/0284185118799519, PubMed 30205701

Publications 2015

Carling U, Dorenberg EJ, Haugvik SP, Eide NA, Berntzen DT, Edwin B, Dueland S, Røsok B (2015)
Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications
Cardiovasc Intervent Radiol, 38 (6), 1532-41
DOI 10.1007/s00270-015-1093-4, PubMed 25832764